AbCellera Biologics Inc. (NASDAQ:NASDAQ:ABCL) Q1 2022 Results Conference Call May 10, 2022 05:00 PM ET Company Participants Tryn Stimart - Chief Legal and Compliance Officer Dr.
Castle Biosciences, Inc. (NASDAQ:NASDAQ:CSTL) Q1 2022 Results Conference Call May 9, 2022 4:30 PM ET Company Participants Camilla Zuckero - Executive Director of Investor Relations and.
908 Devices, Inc. (NASDAQ:NASDAQ:MASS) Q1 2022 Earnings Conference Call May 10, 2022 08:30 ET Company Participants Kelly Gura - Investor Relations Kevin Knopp - Chief Executive Officer.